Navigation Links
Deaconess Health System Selects Omnicell's Medication Management System for Product Reliability and Improved Patient Care
Date:9/27/2010

MOUNTAIN VIEW, Calif., Sept. 27 /PRNewswire/ -- Omnicell, Inc., (Nasdaq: OMCL) a leading provider of medication management systems to acute healthcare facilities, today announced Deaconess Health System's selection of Omnicell's OmniRx® automated medication dispensing systems and SecureVault™ controlled substance security system to improve the safety and efficiency of the medication management process across the health system network. Deaconess chose to replace its current vendor with Omnicell for its clear solutions upgrade path that combines a solid long-term investment with a high level of efficiency, customer service and patient safety.  

Deaconess Health System is a leading, award-winning system of five acute care facilities in southwestern Indiana. Deaconess' use of electronic health records (EHR) has been rated among the top two percent of hospitals in the U.S., for their progress in implementing a paperless medical record. It is one of only 133 hospitals nationwide to be awarded Stage 6 Certification by HIMSS Analytics, a subsidiary of the Health Information and Management Systems Society (HIMSS).

"Omnicell's best-in-class solutions allow clinicians to focus on delivering high levels of patient care, while providing the hospital with medication surveillance and actionable reporting tools," said Joyce Thomas, director of pharmacy, at Deaconess Health System.  "Omnicell solutions will give us the scalability to grow while maintaining a high level of medication safety and high security as we grow to serve more patients in our local communities."  

Omnicell solutions are designed to be easily integrated and interoperable with Deaconess' already existing IT network including the EPIC electronic health records system.  Deaconess Hospital is already in the process of integrating Omnicell solutions at the point-of-care, highlighting the company's customized implementation process.  

"Deaconess is well known in the Midwest and nationwide for its commitment to technology that enhances the patient care experience," said J. Christopher Drew, Omnicell senior vice president, field operations. "We are providing Deaconess with upgradeable solutions to maintain a standard of excellence in medication management and patient safety that will continue well into the future."

About Deaconess Health System

Deaconess Health System is a premiere provider of health care services in southwestern Indiana, western Kentucky and southeastern Illinois. The system includes five hospitals: Deaconess Hospital, a Level II trauma center; The Women's Hospital, dedicated to serving the needs of women and infants; Deaconess Gateway and The Heart Hospital, a new acute care facility; Deaconess Cross Pointe, a behavioral health hospital; and HealthSouth Deaconess Rehabilitation Hospital, specializing in comprehensive medical rehabilitation. Also included in the system are a freestanding cancer center, a health system and physician owned managed care network of preferred hospitals and doctors, two ambulatory surgery centers, 18 ambulatory care sites, two urgent care facilities and multiple partnerships with other health care providers.

For more information, visit http://www.deaconess.com/.

About Omnicell

Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of systems to enable healthcare facilities to increase operational efficiency, enhance patient safety and allow clinicians to spend more time with their patients.

Founded in 1992, Omnicell's medication-use solutions include complete automation systems for the central pharmacy, anesthesia workstations for the operating room, dispensing cabinet systems for nursing units, and safe, secure medication transportation and verification systems to the patient bedside. From a medication's arrival at the receiving dock to its dosing to the patient, Omnicell systems store it, package it, bar code it, order it, issue it, and provide information and controls on its use and reorder.  

Omnicell supply product lines provide a healthcare institution with comprehensive supply chain solutions that result in fast, effective control of costs, capture of charges for payer reimbursement, and timely reorder of supplies. Products range from high-security closed-cabinet systems and software to open-shelf and combination solutions in the nursing unit, cath lab and operating room.  

For more information, visit www.omnicell.com.

OMCL - G


'/>"/>
SOURCE Omnicell, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... March 24, 2017 ShangPharma, a ... and cost-effective drug development and discovery services, ... biotechnology industry, announced today the intent for ... will be consolidating the Contract Research Organizations ... Shanghai ChemPartner. These entities include ChemPartner Shanghai, ...
(Date:3/24/2017)... India , March 24, 2017 A ... market has been growing rapidly as the global sales of Adcetris ... the growth in the antibody drug conjugates market is driven by ... of cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly and ... plans to invest $850 million in its U.S. ... across its U.S. enterprise, including research laboratories, manufacturing ... are being driven by demand for Lilly products, ... medicines in development targeting cancer, pain, diabetes and ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/23/2017)... ... 2017 , ... In 2016 the World Health Organization declared the Zika virus ... Zika-related cases in the Americas within the next year. Lyme disease is one of ... skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne illnesses are ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating ... communities, 16 more public health departments have been awarded national accreditation through the ... million people into the expanding network of communities across the nation whose health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is ... making a huge impact on businesses and individual consumers alike. Laboratories can maximize ... have a value anywhere from $4 trillion to $11 trillion dollars by the year ...
(Date:3/23/2017)... , ... March 23, 2017 ... ... financial services firm serving the families and businesses of the Norwalk and ... program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse ...
Breaking Medicine News(10 mins):